Study Finds Nurse Practitioners and Physician Assistants Would Alter Patient Care Decisions Based on DecisionDx-Melanoma Test Results

01.12.2023 - Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced the publication of a study in the Journal of the Advanced Practitioner in Oncology (JADPRO) that assessed the ... Seite 1

Related Keywords

Chicago ,Illinois ,United States , ,Castle Biosciences Inc ,Dermatology Aesthetic Medicine ,Nasdaq ,Castle Biosciences ,Renata Block ,Advanced Dermatology ,Aesthetic Medicine ,Castle Biosciences Chart ,Astle Biosciences Kurs ,Astle Biosciences Aktie ,